Science
Mechanism of Action
This synthetic peptide, composed of 11 amino acids including alanine, arginine, glutamine, histidine, leucine, and phenylalanine, functions by specifically reducing the expression of adipogenetic factors. These biological signals are well-established promoters of fat accumulation within tissues, offering a targeted approach to minimizing localized fat deposits.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Clinical observations from injectable treatments indicate Oligopeptide-61's capacity to reduce adipogenetic factors, leading to a notable decrease in fat deposition. This effect is specifically utilized in addressing 'shadows and bags under the eyes', with recommended protocols involving 2-3 injection sessions at 2-week intervals. It is crucial to note that these efficacy findings pertain to direct injectable administration.
Transparency
Dusting Analysis
The available research data primarily focuses on injectable applications and does not provide sufficient information regarding effective topical concentrations or widespread cosmetic formulation trends for Oligopeptide-61 to determine if it is commonly 'dusted' in skincare products.
The Formula
Formulation
Stability
No specific stability notes for Oligopeptide-61 were identified in the available research.
Safety
Safety Profile
No specific safety assessments from CIR, SCCS, or FDA were found for Oligopeptide-61. However, the broader class of oligopeptides is generally regarded as having a favorable safety profile, though individual ingredient assessment is still beneficial.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Oligopeptide-61 demonstrates clear efficacy in injectable applications for reducing fat deposition, comprehensive data regarding its specific topical efficacy, optimal concentration, and safety for use in cosmetic skincare formulations remains limited.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources